Toggle menu Toggle search

EP3: Pharmacovigilance & Adverse Reactions

14 June 2021 Print

TO BE RELEASED ON 14TH JUNE 2021

In our final part of this 3 part series on Regulatory Affairs in Complementary Medicine, we welcome back Sue Woldt, Senior Regulatory Affair Manager at Integria Healthcare.

In Part 3 of this series, Sue will cover Adverse Reactions and Pharmacovigilance and your responsibilities as a practitioner. 

Sue discusses: 

  • Definition of Pharmacovigilance (PV)
  • What is the difference between an adverse reaction and adverse event
  • Who is responsible for reporting adverse reactions and events
  • Reporting an adverse reaction
  • Wider implications- labelling and warnings

Quick Links: